Pharma

Your Article Summary

See Latest Articles

Enzon Discontinues its Plan to Spin-off its Biotechnology Business
Enzon Pharmaceuticals, 01/07/09

Enzon Pharmaceuticals, Inc. announced that the Board of Directors has decided to discontinue its previously announced plan to spin-off the biotechnology business into a separate public company. The Company will continue to focus on the fundamentals of the business. This includes the continued improvement of its operating efficiency and the advancement of its novel R&D portfolio.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09

Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09

PR distribution service for the biotech industry
b3c newswire, 12/07/09

 See all of Biotechnology

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09

Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09

Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09

 See all of Regulatory Issues